logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
Q

Qifeng Chen

Sichuan University
H指数:26
被引数:1,952

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Combining immune checkpoint inhibitors and molecular-targeted agents with hepatic arterial infusion chemotherapy for hepatocellular carcinoma with inferior vena cava and/or right atrium tumor thrombus

免疫检查点抑制剂和分子靶向药物联合肝动脉灌注化疗治疗肝癌合并下腔静脉和/或右心房癌栓

HEPATOLOGY INTERNATIONAL
IF6.1
2025-02-110
PRE
Zhong, Suixing; Yi, Junzhe; Chen, Song; Mo, Xiaoyan; Chen, Qifeng; Guo, Wenbo; Jiang, Xiongying; Mu, Luwen; Hu, Yue; Wang, Jiongliang; Song, Yujia; Xu, Jie; Tan, Genjun; Shi, Ming; Chen, Minshan; Lyu, Ning; Zhao, Ming
Hepatic arterial infusion therapy for advanced hepatocellular carcinoma after systemic treatment failure: Multicenter, real-world study

全身治疗失败后晚期肝细胞癌的肝动脉灌注治疗：多中心真实世界研究

HEPATOLOGY RESEARCH
IF3.4
2024-01-196
PRE
Yi, Jun-Zhe; Zhu, Zhi-Jian; Liu, Gong-Wei; Zhang, Yi-Min; Xu, Jie; Wu, Xin-Tong; Ding, Ke; Liu, Jian-Chao; Zhang, Ke-Fei; Jiang, Xiong-Ying; Chen, Qi-Feng; Hu, Yue; Chen, Song; Zhong, Sui-Xing; Wang, Jiong-Liang; Lyu, Ning; Zhao, Ming
Cost-effectiveness and prognostic model of hepatic arterial infusion chemotherapy for hepatocellular carcinoma with high tumor burden and/or Vp4 tumor thrombus compared with sorafenib: a post-hoc analysis of the FOHAIC-1 trial

与索拉非尼相比，肝动脉灌注化疗治疗高肿瘤负荷和/或Vp4癌栓肝细胞癌的成本效益和预后模型: FOHAIC-1试验的事后分析

INTERNATIONAL JOURNAL OF SURGERY
IF10.1
2023-09-045
OAAI
Chen, Qi-Feng; Lyu, Ning; Wang, Xun; Jiang, Xiong-Ying; Hu, Yue; Chen, Song; Zhong, Sui-Xing; Huang, Zi-Lin; Chen, Minshan; Zhao, Ming

研究方向

暂未获取到该数据
W
Wang Li
H 指数:30论文数:287被引数:2,572
吴
吴沛宏
H 指数:37论文数:171被引数:3,846
L
Lujun Shen
H 指数:25论文数:193被引数:1,768
Tao Huang 封面图
Tao Huang
H 指数:54论文数:1,048被引数:1.1万
赵
赵明
H 指数:54论文数:338被引数:1.0万
N
Ning Lyu
H 指数:24论文数:96被引数:2,239
K
Kangkang Chen
H 指数:25论文数:130被引数:2,567
X
Xiongying Jiang
H 指数:14论文数:53被引数:664
J
Jun‐Zhe Yi
H 指数:6论文数:25被引数:186
S
Song Chen
H 指数:3论文数:6被引数:60